Connection

FREDERICK LANG to Antineoplastic Agents

This is a "connection" page, showing publications FREDERICK LANG has written about Antineoplastic Agents.
Connection Strength

0.406
  1. Stem Cell Therapy of Gliomas. Prog Neurol Surg. 2018; 32:124-151.
    View in: PubMed
    Score: 0.131
  2. Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation Therapy. Clin Cancer Res. 2022 05 02; 28(9):1979-1990.
    View in: PubMed
    Score: 0.043
  3. Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors. J Neurointerv Surg. 2020 Feb; 12(2):197-203.
    View in: PubMed
    Score: 0.036
  4. Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas. Clin Cancer Res. 2017 Oct 15; 23(20):6215-6226.
    View in: PubMed
    Score: 0.031
  5. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas. Cytotherapy. 2017 04; 19(4):445-457.
    View in: PubMed
    Score: 0.030
  6. Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway. J Neurooncol. 2012 May; 107(3):487-501.
    View in: PubMed
    Score: 0.021
  7. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011 Jan; 121(1):161-73.
    View in: PubMed
    Score: 0.019
  8. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst. 2007 Sep 19; 99(18):1410-4.
    View in: PubMed
    Score: 0.015
  9. Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression. J Proteome Res. 2007 Feb; 6(2):869-75.
    View in: PubMed
    Score: 0.015
  10. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst. 2006 May 03; 98(9):625-36.
    View in: PubMed
    Score: 0.014
  11. Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses. J Neurooncol. 2003 Dec; 65(3):237-46.
    View in: PubMed
    Score: 0.012
  12. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation. Cancer Res. 2002 Feb 15; 62(4):1069-76.
    View in: PubMed
    Score: 0.011
  13. A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities. Nat Commun. 2020 06 10; 11(1):2935.
    View in: PubMed
    Score: 0.009
  14. Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article. J Neurosurg. 2011 Mar; 114(3):576-84.
    View in: PubMed
    Score: 0.005
  15. Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas. Curr Gene Ther. 2009 Oct; 9(5):422-7.
    View in: PubMed
    Score: 0.004
  16. Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery. 2007 Nov; 61(5):1031-7; discussion 1037-8.
    View in: PubMed
    Score: 0.004
  17. Brain metastases. Curr Probl Surg. 2004 Aug; 41(8):665-741.
    View in: PubMed
    Score: 0.003
  18. Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome. J Neurooncol. 2004 Feb; 66(3):313-25.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.